3-41235763-G-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PS1_Very_StrongPM2PP3_ModeratePP5_Moderate
The NM_001904.4(CTNNB1):c.1723G>C(p.Gly575Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G575A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001904.4 missense
Scores
Clinical Significance
Conservation
Publications
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
- exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNB1 | NM_001904.4 | c.1723G>C | p.Gly575Arg | missense_variant | Exon 11 of 15 | ENST00000349496.11 | NP_001895.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | ENST00000349496.11 | c.1723G>C | p.Gly575Arg | missense_variant | Exon 11 of 15 | 1 | NM_001904.4 | ENSP00000344456.5 | ||
| CTNNB1 | ENST00000645982.1 | c.1723G>C | p.Gly575Arg | missense_variant | Exon 11 of 16 | ENSP00000494845.1 | ||||
| CTNNB1 | ENST00000715152.1 | n.1723G>C | non_coding_transcript_exon_variant | Exon 11 of 16 | ENSP00000520353.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Severe intellectual disability-progressive spastic diplegia syndrome Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.72 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.60 (>=0.6, sensitivity 0.72 and precision 0.9)]. Different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000208674). The variant has been previously reported as de novo in a similarly affected individual (PMID: 33350591). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at